Evidence map›Paper›PMID 21041656›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands.

Katharina Brandl, Lei Sun, Christina Neppl, Owen M Siggs, Sylvain M Le Gall, Wataru Tomisato, Xiaohong Li, Xin Du, Daniela N Maennel, Carl P Blobel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Amphiregulin-producing γδ T cells are vital for safeguarding oral barrier immune homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Katharina BrandlDepartment of Genetics, The Scripps Research Institute, La Jolla, CA 92037, USA.
Lei Sun
Christina Neppl
Owen M Siggs
Sylvain M Le Gall
Wataru Tomisato
Xiaohong Li
Xin Du
Daniela N Maennel
Carl P Blobel
Bruce Beutler
Scripps Research Institute · USHospital for Special Surgery · USUniversity of Regensburg · DE

Funding

Mutagenetic analysis of LPS responsesR37GM067759 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI BEUTLER, BRUCE A · 2007 to 2016
$8.6M
iRhoms 1 and 2: Key regulators of ADAM17-dependent EGFR signalingR01GM064750 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BLOBEL, CARL PETER · 2002 to 2019
$6.1M
NIAID NIH HHS HHSN272200700038CNIGMS NIH HHS R01 GM064750NIGMS NIH HHS R37 GM067759
6 · The paper itself

Abstract

Toll-like receptors (TLRs) trigger intestinal inflammation when the epithelial barrier is breached by physical trauma or pathogenic microbes. Although it has been shown that TLR-mediated signals are ultimately protective in models of acute intestinal inflammation [such as dextran sulfate sodium (DSS)-induced colitis], it is less clear which cells mediate protection. Here we demonstrate that TLR signaling in the nonhematopoietic compartment confers protection in acute DSS-induced colitis. Epithelial cells of MyD88/Trif-deficient mice express diminished levels of the epidermal growth factor receptor (EGFR) ligands amphiregulin (AREG) and epiregulin (EREG), and systemic lipopolysaccharide administration induces their expression in the colon. N-ethyl-N-nitrosourea (ENU)-induced mutations in Adam17 (which is required for AREG and EREG processing) and in Egfr both produce a strong DSS colitis phenotype, and the Adam17 mutation exerts its deleterious effect in the nonhematopoietic compartment. The effect of abrogation of TLR signaling is mitigated by systemic administration of AREG. A TLR→MyD88→AREG/EREG→EGFR signaling pathway is represented in nonhematopoietic cells of the intestinal tract, responds to microbial stimuli once barriers are breached, and mediates protection against DSS-induced colitis.

Indexed as

Signal TransductionAdaptor Proteins, Vesicular TransportAmphiregulinAnimalsColitisDextran SulfateEGF Family of ProteinsEpidermal Growth FactorEpiregulinErbB ReceptorsGlycoproteinsHematopoietic SystemIntercellular Signaling Peptides and ProteinsLigandsLipopolysaccharidesMetagenomeAdaptor Proteins, Vesicular TransportAmphiregulinAreg protein, mouseDextran SulfateEGF Family of ProteinsEpidermal Growth FactorEpiregulinErbB ReceptorsEreg protein, mouseGlycoproteinsIntercellular Signaling Peptides and ProteinsLigandsLipopolysaccharidesMyeloid Differentiation Factor 88Ticam1 protein, mouseToll-Like Receptors

Identifiers

PMID21041656
PMCPMC2993336
OpenAlexW2157350742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.